Otyłość a cukrzyca

• Authors: Miazgowski Tomasz
• Languages of publication: PL

Keywords

PL

otyłość; cukrzyca; metabolizm; tłuszcz trzewny; powolne przewlekłe zapalenie

• Publisher: Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
• Journal: Family Medicine & Primary Care Review
• Year: 2012
• Issue: 3
• Pages: 462-467

Contributors

author

Miazgowski Tomasz

References

• James WP. The epidemiology of obesity: the size of the problem. J Intern Med 2008; 263: 336−352.
• http://www.idf.org/diabetesatlas/5e/the-global-burden.
• Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988−1994. Diab Care 1998; 21: 518−524.
• Resnick HE, Valsania P, Halter JB, et. al. Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults. J Epidemiol Community Health 2000; 54: 596−602.
• Primeau V, Coderre L, Karelis AD, et al. Characterizing the profile of obese patients who are metabolically healthy.Int J Obes (Lond) 2011; 35: 971−981.
• Bluher M. The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals. Curr Opin Lipidol 2010; 21:38–43.
• Pajunen P, Kotronen A, Korpi-Hyövälti E, et al. Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. BMC Public Health 2011; 11: 754.
• St-Onge MP, Janssen I, Heymsfield SB. Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual. Diab Care 2004; 27: 2222−2228.
• Katsuki A, Sumida Y, Urakawa H, et al. Increased oxidative stress is associated with serum levels of triglyceride,insulin resistance, and hyperinsulinemia in Japanese metabolically obese, normal-weight men. Diab Care 2004; 27:631–632.
• Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006; 91: 2906−2912.
• Porzezińska J, Krzyżanowska-Świniarska B, Miazgowski T, i wsp. Metaboliczna otyłość u osób z prawidłową masą ciała a 11β-dehydrogenaza hydroksysteroidowa typu 1 (11β-HSD1). Endokrynol Otyłość 2009; 5: 73−80.
• Marques-Vidal P, Chiolero A, Paccaud F. Large differences in the prevalence of normal weight obesity using various cut-offs for excess body fat. E-SPEN 2008; 3: 159−162.
• Marques-Vidal P, Pécoud A, Hayoz D, et al. Normal weight obesity: relationship with lipids, glycaemic status, liver enzymes and inflammation. Nutr Metab Cardiovasc Dis 2010; 20: 669−675
• Romero-Corral A, Somers VK, Sierra-Johnson J, et al. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J 2010; 31: 737−746.
• Liu J, Fox CS, Hickson DA, et al. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. J Clin Endocrinol Metab 2010; 95: 5419−5426.
• Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med 2002; 162: 2074−2079.
• Bergman RN, Stefanovski D, Buchanan TA, et al. A better index of body adiposity. Obesity (Silver Spring) 2011; 19:1083−1089.
• Stettler N, Stallings VA, Troxel AB, et al. Weight gain in the first week of life and overweight in adulthood: a cohort study of European American subjects fed infant formula. Circulation 2005; 111: 1879−1903.
• Plagemann A, Harder T, Rake A, et al. Perinatal elevation of hypothalamic insulin, acquired malformation of hypothalamic galaninergic neurons and syndrome X-like alterations in aduldhood of neonatally overfed rats. Brain Res 1999; 836: 146−155.
• Gluckman PD, Hanson MA, Spencer HG. Predictive adaptive responses and human evolution. Trends Ecol Evol 2005; 20: 527−353.
• Teixeira-Lemos E, Nunes S, Teixeira F, et al. Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties. Cardiovasc Diabetol 2011; 10: 12.
• Boden G. Free fatty acids – the link between obesity and insulin resistance. Endocr Pract 2001; 7: 44−51.
• Sattar N, Nelson SM. Adiponectin, diabetes, and coronary hart disease in older persons: unraveling the paradox. J Clin Endocrinol Metab 2008; 93: 3199−3201.
• Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003; 112: 1785−1788.
• Tan BK, Adya R, Randeva HS. Omentin: a novel link between inflammation, diabesity, and cardiovascular disease.Trends Cardiovasc Med 2010; 20: 143−148